Ulisse Biomed
Revolutionizing healthcare through innovative diagnostic platforms that enable early detection and better outcomes.
Browse related lists
Related on Causeartist
- Investors
Ulisse Biomed has transformed into Helyx Industries, a comprehensive molecular biology solutions company. The company operates through three integrated divisions - Hyris, Vytro, and Mytho - offering advanced PCR solutions, next-generation sequencing technologies, and a unique proprietary platform for molecular diagnostics.
The company represents an evolution of Ulisse Biomed's expertise, rebranding to better reflect their expanded capabilities and integrated approach. This transformation demonstrates their commitment to advancing molecular biology through a unified platform that brings together diverse technological solutions.
Helyx Industries positions itself as a significant player in the molecular diagnostics space, providing tools that are essential for modern biological research and healthcare applications. Their comprehensive suite of molecular biology solutions has the potential to accelerate scientific discovery and improve diagnostic capabilities across various fields.
Key benefits
Impact-Driven Model
Helyx Industries creates impact by providing comprehensive molecular biology solutions that enable faster and more accurate biological research and diagnostics. Their integrated p…
Core Offering
Ulisse Biomed has transformed into Helyx Industries, a comprehensive molecular biology solutions company.
Why It Matters
The company operates through three integrated divisions - Hyris, Vytro, and Mytho - offering advanced PCR solutions, next-generation sequencing technologies, and a unique propriet…
Helyx Industries creates impact by providing comprehensive molecular biology solutions that enable faster and more accurate biological research and diagnostics. Their integrated platform of PCR, sequencing, and proprietary technologies helps researchers and healthcare professionals advance scientific understanding and improve patient outcomes.
The company's three-division structure allows them to offer complete solutions rather than fragmented tools, potentially accelerating research timelines and improving the efficiency of molecular diagnostics across multiple applications.
Now operating as Helyx Industries, the company unites its molecular biology expertise across three integrated divisions—Hyris, Vytro, and Mytho—delivering PCR, next-generation sequencing, and proprietary diagnostics solutions to accelerate research and improve diagnostic capabilities.
Investors
Frequently asked questions
- What does Ulisse Biomed do?
- Ulisse Biomed has transformed into Helyx Industries, a comprehensive molecular biology solutions company. The company operates through three integrated divisions - Hyris, Vytro, and Mytho - offering advanced PCR solutions, next-generation sequencing technologies, and a unique proprietary platform for molecular diagnostics. The company represents an evolution of Ulisse Biomed's expertise, rebra…
- Where is Ulisse Biomed based?
- Ulisse Biomed is based in Italy.
- What sector does Ulisse Biomed operate in?
- Ulisse Biomed operates in the Health & Wellness sector.
- Who has invested in Ulisse Biomed?
- Published funders on Causeartist include Astanor Ventures.
